These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 14633873

  • 1. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.
    Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Nagamura Y, Kondo T, Oshima H, Nomura M, Ezaki K, Hishida H.
    Clin Chem; 2003 Dec; 49(12):2020-6. PubMed ID: 14633873
    [Abstract] [Full Text] [Related]

  • 2. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.
    Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H.
    Am J Cardiol; 2002 Mar 15; 89(6):691-5. PubMed ID: 11897211
    [Abstract] [Full Text] [Related]

  • 3. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.
    Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T.
    Circ J; 2007 May 15; 71(5):631-5. PubMed ID: 17456983
    [Abstract] [Full Text] [Related]

  • 4. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies.
    Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T.
    Heart Vessels; 2006 Nov 15; 21(6):344-9. PubMed ID: 17143708
    [Abstract] [Full Text] [Related]

  • 5. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG, Riedlinger J, Buchner S, Birner C, Resch M, Lubnow M, Debl K, Buesing M, Huedig H, Riegger G, Luchner A.
    Clin Chem Lab Med; 2011 Nov 15; 49(11):1899-906. PubMed ID: 21892905
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis.
    Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, Ishikawa T, Kurokawa H, Hirano T, Kondo T, Nagamura Y, Ezaki K, Hishida H.
    Clin Chim Acta; 2001 Oct 15; 312(1-2):69-79. PubMed ID: 11580911
    [Abstract] [Full Text] [Related]

  • 7. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May 15; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 8. Brain natriuretic peptide correlates with troponin T in patients with renal failure.
    Sahinarslan A, Guz G, Okyay K, Torer N, Bali M, Sindel S, Cengel A.
    Acta Cardiol; 2007 Apr 15; 62(2):171-6. PubMed ID: 17536606
    [Abstract] [Full Text] [Related]

  • 9. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure.
    Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, Januzzi JL.
    Clin Chem; 2007 Mar 15; 53(3):412-20. PubMed ID: 17259237
    [Abstract] [Full Text] [Related]

  • 10. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.
    Demir M, Kanadasi M, Akpinar O, Dönmez Y, Avkarogullari M, Alhan C, Inal T, San M, Usal A, Demirtas M.
    Angiology; 2007 Mar 15; 58(5):603-9. PubMed ID: 18024945
    [Abstract] [Full Text] [Related]

  • 11. Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase.
    Niizuma S, Iwanaga Y, Washio T, Ashida T, Harasawa S, Miyazaki S, Matsumoto N.
    Kidney Blood Press Res; 2019 Mar 15; 44(5):1050-1062. PubMed ID: 31487705
    [Abstract] [Full Text] [Related]

  • 12. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL, Donckier JE, Robert A, Laloux O, van Linden F, Ahn S, Ketelslegers JM, Rousseau MF.
    Eur J Clin Invest; 1998 Aug 15; 28(8):636-42. PubMed ID: 9767358
    [Abstract] [Full Text] [Related]

  • 13. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May 15; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 14. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS.
    Circulation; 2007 Jul 17; 116(3):249-57. PubMed ID: 17592074
    [Abstract] [Full Text] [Related]

  • 15. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J, de Antonio M, Galán A, Vila J, Zamora E, Urrutia A, Bayes-Genis A.
    Mayo Clin Proc; 2013 Mar 17; 88(3):234-43. PubMed ID: 23384388
    [Abstract] [Full Text] [Related]

  • 16. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE, Liu PP, Erthal F, deKemp RA, Wells G, O'Meara E, Garrard L, Beanlands RSB, Mielniczuk LM.
    Can J Cardiol; 2017 Nov 17; 33(11):1478-1488. PubMed ID: 28966019
    [Abstract] [Full Text] [Related]

  • 17. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure.
    Niizeki T, Takeishi Y, Arimoto T, Takahashi T, Okuyama H, Takabatake N, Nozaki N, Hirono O, Tsunoda Y, Shishido T, Takahashi H, Koyama Y, Fukao A, Kubota I.
    Circ J; 2005 Aug 17; 69(8):922-7. PubMed ID: 16041160
    [Abstract] [Full Text] [Related]

  • 18. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.
    Clin Chem; 2010 Nov 17; 56(11):1718-24. PubMed ID: 20844063
    [Abstract] [Full Text] [Related]

  • 19. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J, CORONA Study Group.
    Circ Heart Fail; 2014 Jan 17; 7(1):96-103. PubMed ID: 24284025
    [Abstract] [Full Text] [Related]

  • 20. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J.
    Scand J Clin Lab Invest; 2004 Jan 17; 64(7):667-76. PubMed ID: 15513324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.